Effects of cis9,trans11 Conjugated Linoleic Acid on Platelet Function, Markers of Haemostasis and Inflammation on Humans.

Trial Profile

Effects of cis9,trans11 Conjugated Linoleic Acid on Platelet Function, Markers of Haemostasis and Inflammation on Humans.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Nov 2015

At a glance

  • Drugs Conjugated linoleic acid (Primary)
  • Indications Cardiovascular disorders
  • Focus Biomarker; Pharmacodynamics
  • Acronyms CLASS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Nov 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 07 Nov 2012 Planned End Date changed from 1 Oct 2011 to 1 Nov 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top